GW BOTANICALS Trademark
Serial Number: 79237068
Trademark Classes
Owner Contact Info
BUILDING 730 KENT SCIENCE PARK
SITTINGBOURNE, KENT ME9 8AG , GB
Entity Type: 24
Legal Representation
Correspondence Address
Jennifer M. Hetu Honigman LLP
39400 Woodward Avenue, Suite 101
Bloomfield Hills, MI 48304-5151
UNITED STATES
Trademark Details
Filing Date
April 24, 2018
Registration Date
Not Registered
Goods & Services
Agricultural and horticultural products; seeds; seedlings for plant breeding; flowers; plants; plant residues (raw materials); fresh herbs; foodstuffs and beverages for animals
Pharmaceutical, medical and veterinary preparations and substances; pharmaceutical preparations and substances for the treatment of epilepsy; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome and chromosome disorders; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; medicinal infusions for the treatment of epilepsy, convulsions and seizures; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; dietary supplements for humans and animals; dietetic food and substances adapted for medical or veterinary use; food for babies; herb teas for medicinal purposes; medications for the treatment of multiple sclerosis, pain associated with cancer, neuropathies and rheumatoid arthritis; medicines for the treatment of symptoms including pain, muscle spasticity and spasms, bladder problems and sleep disorders; medications for the treatment of conditions to which neuropathic pain is associated, including multiple sclerosis, cancer, spinal cord injury, physical trauma and peripheral neuropathy resulting from diabetes; medicines for the treatment of anorexia-cachexia, the result of cancer or AIDS, and nausea, and secondary vomiting due to chemotherapy treatments; pharmaceutical preparations with cannabinoids as active ingredient
